EMEA-000237-PIP01-08-M10
Key facts
| Invented name |
Edarbi
|
| Active substance |
Azilsartan medoxomil
|
| Therapeutic area |
Cardiovascular diseases
|
| Decision number |
P/0530/2021
|
| PIP number |
EMEA-000237-PIP01-08-M10
|
| Pharmaceutical form(s) |
|
| Condition(s) / indication(s) |
Treatment of hypertension
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
Takeda Development Centre Europe Ltd
Email: Pediatrics@tgrd.com |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|